Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fenhuma 100microgram sublingual tablets
0407020A0BXAAAW
|
Fenhuma | Fentanyl | Central Nervous System | 4 |
|
Fentanyl 67microgram sublingual tablets sugar free
0407020A0AACHCH
|
Fentanyl | Fentanyl | Central Nervous System | 4 |
|
Fenylat 100micrograms/hour transdermal patches
0407020A0BZAEAH
|
Fenylat | Fentanyl | Central Nervous System | 4 |
|
Haloperidol 1.5mg/5ml oral liquid
0402010J0AABBBB
|
Haloperidol | Haloperidol | Central Nervous System | 4 |
|
Iremia 400microgram sublingual tablets
0407020A0BYAPAZ
|
Iremia | Fentanyl | Central Nervous System | 4 |
|
Ixyldone 60mg modified-release tablets
0407020ADBTAGAQ
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 4 |
|
Lecaent 100mg capsules
0408010AEBDADAD
|
Lecaent | Pregabalin | Central Nervous System | 4 |
|
Methylphenidate 15mg/5ml oral solution
0404000M0AAAXAX
|
Methylphenidate hydrochloride | Methylphenidate hydrochloride | Central Nervous System | 4 |
|
Midazolam 10mg/5ml oral liquid
0408020V0AAAFAF
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | 4 |
|
Morphine 0.2% in Intrasite gel
0407020Q0AAFYFY
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 4 |
|
Optimax 500mg tablets
0403040S0BBAAAB
|
Optimax | Tryptophan | Central Nervous System | 4 |
|
Orlos 60mg capsules
0405010P0BEAAAB
|
Orlos | Orlistat | Central Nervous System | 4 |
|
Phenobarbital 125mg/5ml oral liquid
0408010N0AACXCX
|
Phenobarbital | Phenobarbital | Central Nervous System | 4 |
|
Phenobarbital 60mg/1ml solution for injection ampoules
0408010P0AAAGAG
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | 4 |
|
Phenobarbital 90mg/5ml oral liquid
0408010N0AAEAEA
|
Phenobarbital | Phenobarbital | Central Nervous System | 4 |
|
Phenytoin sodium 50mg/5ml oral liquid
0408010Q0AAAXAX
|
Phenytoin sodium (Systemic) | Phenytoin sodium | Central Nervous System | 4 |
|
Psytixol 100mg/1ml solution for injection ampoules
0402020G0BCADAB
|
Psytixol | Flupentixol decanoate | Central Nervous System | 4 |
|
Sertraline 50mg/5ml oral solution
0403030Q0AAAVAV
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 4 |
|
Sodium valproate 300mg suppositories
0408010W0AABCBC
|
Sodium valproate | Sodium valproate | Central Nervous System | 4 |
|
Sodium valproate 500mg/5ml oral liquid
0408010W0AAA7A7
|
Sodium valproate | Sodium valproate | Central Nervous System | 4 |
|
Sycrest 10mg sublingual tablets
0402030R0BBAAAA
|
Sycrest | Asenapine | Central Nervous System | 4 |
|
Tiagabine 2.5mg/5ml oral suspension
0408010ABAAAEAE
|
Tiagabine | Tiagabine | Central Nervous System | 4 |
|
Turgeon 35micrograms/hour transdermal patches
0407020B0BSAAAE
|
Turgeon | Buprenorphine | Central Nervous System | 4 |
|
Wakix 18mg tablets
0404000W0BBAAAA
|
Wakix | Pitolisant hydrochloride | Central Nervous System | 4 |
|
Zaponex 50mg orodispersible tablets
0402010C0BDAEAJ
|
Zaponex | Clozapine | Central Nervous System | 4 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.